Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP752439.RAY5NWgx3_Ikb97A395H_3leWKJ39XkQDmpqZOYsLZDTo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP752439.RAY5NWgx3_Ikb97A395H_3leWKJ39XkQDmpqZOYsLZDTo130_assertion type Assertion NP752439.RAY5NWgx3_Ikb97A395H_3leWKJ39XkQDmpqZOYsLZDTo130_head.
- NP752439.RAY5NWgx3_Ikb97A395H_3leWKJ39XkQDmpqZOYsLZDTo130_assertion wasGeneratedBy ECO_0000203 NP752439.RAY5NWgx3_Ikb97A395H_3leWKJ39XkQDmpqZOYsLZDTo130_provenance.
- NP752439.RAY5NWgx3_Ikb97A395H_3leWKJ39XkQDmpqZOYsLZDTo130_assertion wasDerivedFrom befree-20150227 NP752439.RAY5NWgx3_Ikb97A395H_3leWKJ39XkQDmpqZOYsLZDTo130_provenance.
- NP752439.RAY5NWgx3_Ikb97A395H_3leWKJ39XkQDmpqZOYsLZDTo130_assertion SIO_000772 20142599 NP752439.RAY5NWgx3_Ikb97A395H_3leWKJ39XkQDmpqZOYsLZDTo130_provenance.
- NP752439.RAY5NWgx3_Ikb97A395H_3leWKJ39XkQDmpqZOYsLZDTo130_assertion evidence source_evidence_literature NP752439.RAY5NWgx3_Ikb97A395H_3leWKJ39XkQDmpqZOYsLZDTo130_provenance.
- NP752439.RAY5NWgx3_Ikb97A395H_3leWKJ39XkQDmpqZOYsLZDTo130_assertion description "[Because p53 immunopositivity is an adverse prognostic marker in pediatric medulloblastoma and TP53 mutations are associated with chemotherapy and radiation therapy resistance, we aimed to determine the extent and role of TP53 mutations in pediatric medulloblastoma treatment failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752439.RAY5NWgx3_Ikb97A395H_3leWKJ39XkQDmpqZOYsLZDTo130_provenance.